|
US$16.00-40.00
|
10 Pieces
(MOQ)
|
Basic Info.
Certification
CE, ISO13485, Sfda
Logo Printing
With Logo Printing
Hyaluronic Acid
Non Cross-Linked Derivative
Department
Pelvic Surgery
Another Name
Absorbable Adhesion Barrier Gel
Supply Type
Distribute, OEM, Obl
Characterist
Better Biocompatibility
Use
Surgical Operation Ends Catheter Into The Uterine
Transport Package
Blister in Color Box
Specification
5.0ml 10mg/ml Syringe
Production Capacity
50000PCS/Year
Product Description
Hyaluronic Acid Sodium Hyaluronate Liquid for Anti-Adhesion
Product Description
1.Overview:
The products are made from sodium hyaluronate through cross-linking. They apply to laparoscopic surgery and other abdominal and pelvic surgeries, and can effectively reduce the incidence of postoperative adhesions and degree of adhesion.
Spread the product on the rough surface of a woinf liable to postoperative adhesion.With no surface groups in its molecule and no covalet binding with the protein,it can exist as free chain in the body for lubrication,moisture preservation and mechanical isolation,prevening adhesions.
2. Background:
Peritoneum may be adhesions when in self-healing process after operation damaged. Critical period for peritoneal repair period is 5-7 days, which is adhesion forming. So in this self-healing process 5 to 7 days,sodium hyaluronate for anti-adhesion is a necessary drug.
3.Scope of application:
Lubrication, moisture preservation , preventing adhesions in the abdominal and pelvic surgery.
4.Product advantages:
1. Non-animal source
2. Good biocompatibility
3. High viscoelasticity
4. High lubricity
5. High physical alterability
6. Promote wound healing
| Specification | concentration |
| 1.0ml | 10mg/ml |
| 2.0ml | 10mg/ml |
| 2.5ml | 10mg/ml |
| 3ml | 10mg/ml |
| 4ml | 10mg/ml |
| 5ml | 10mg/ml |
| 10ml/20ml | 10mg/ml |
5. Principle:
Detailed Photos
Main Products
Company Profile